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Collectively, these studies assessed the load-bearing, low-friction, 
and wear-resistant biomechanical properties of articulating cartilage 
and the lubrication capabilities of SF. They provide insight into 
the mechanobiological mechanisms by which cartilage may fail 
to maintain its low-friction and low-wear properties during joint 
articulation. The presence of a focal defect, the loss of articular 
TVSGBDFJOUFHSJUZBOEUIFMPTTPG4'MVCSJDBUJPODBOFBDITJHOJ¾DBOUMZ
alter intra-tissue strain distributions. 
Excessive strains in cartilage may be detrimental for a number 
of reasons. Strains may exceed levels that are injurious to cells, 
causing their death,11 and they may also exceed levels that cause 
damage to the extracellular matrix.12 Even in the absence of acute 
damage, moderate increases in the local strains or sliding distances 
could contribute to accelerated cartilage fatigue and wear. 
4JHOJ¾DBOUBMUFSBUJPOTJO4'DPNQPTJUJPOBOEGVODUJPODBOMFBEUPQPPS
CPVOEBSZMVCSJDBUJPOBIJHIGSJDUJPODPFG¾DJFOUBOEFYDFTTJWFXFBS
5IFEFUSJNFOUBM¿VJEQSPQFSUJFTBGUFSBDVUFKPJOUJOKVSZNBZBMTPCF
present after cartilage repair. It may be the direct loss of boundary 
lubrication or the friction-induced tissue shear which contributes to 
the progression of cartilage wear. Biological or physical treatments 
to modulate lubrication may protect the articular cartilage from 
damage, as might a moderation of physical demands. 
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24.1
Quantitative cartilage MR imaging in cartilage repair and 
osteoarthritis
F. Eckstein, Austria 
Magnetic resonance imaging (MRI), radiological scoring systems, 
and quantitative image analysis technology have recently started 
to provide a wealth of new information on articular cartilage and 
other articular tissues under physiological and patho-physiological 
conditions. These techniques have been applied to the study of 
healthy joints and to those suffering from traumatic and degenerative 
disease. 
In the context of cartilage repair, MRI has also a high potential and 
can make the following contributions: 
a) help estimating the size, nature and location of lesions 
preoperatively, in order to optimize surgical planning 
b) evaluate the quality and success of tissue repair processes after 
surgical treatment. 
c) Monitor degenerative changes in the joint after cartilage repair, 
potentially in comparison to patients who have not been treated for 
similar cartilage lesions. 
ad a): MR sequences used for evaluating cartilage lesions and other 
articular tissues encompass T1-weighted spoiled gradient recalled 
acquisition at steady state (SPGR=spoiled gradient echo or FLASH 
= fast low angle shot) with fat suppression 1-5,5-9 or selective water 
excitation (we) 10, and fat-suppressed T2- or intermediate (IM) 
weighted fast spin echo (FSE) sequences 4,6,11-14. The advantage 
of SPGR/FLASH sequences is the high spatial resolution, but this 
is at the price of a relatively long acquisition time. Using a model 
PGBSUJ¾DJBMDBSUJMBHF MFTJPOT JOSBCCJU KPJOUT JUXBTTIPXOUIBU UIF
ability to detect small cartilage lesions critically depended on the 
spatial resolution of the imaging sequence, and that achieving a high 
SFTPMVUJPOKVTUJ¾FETPNFEFHSFFPGTBDSJ¾DFJO4/3BOEDPOUSBTUUP
noise ratios (CNR) 15. With IM- and T2-weighted sequences, however, 
the internal structure of the cartilage displays more heterogeneous 
signal and “internal” pathological changes may be more easily 
detectable. Moreover, cartilage surface lesions are well depicted 
with these sequences, because of the steep gradient of signal 
JOUFOTJUZCFUXFFO UIF DBSUJMBHFBOE UIF TZOPWJBM¿VJEQBSUJDVMBSMZ
when effusion is present. Other degenerative of traumatic changes of 
articular or periarticular tissues, such as bone marrow abnormalities, 
meniscal and ligament injuries and joint effusion are well visualized 
with fat-suppressed T2- or IM-weighted FSE images and non fat-
suppressed T1-weighted sequences; synovitis, however is usually 
most reliably visualized using contrast- (Gd-DTPA) enhanced 
sequences. 
Most scoring methods for articular cartilage lesions grade lesion 
severity from 0 - 3 or 4 based on subjective evaluations and commonly 
differentiate between cartilage lesions of less than 50% depth, more 
than 50% depth, and full thickness cartilage lesions. Peterfy et al. 
4 have described a comprehensive MRI scoring system (WORMS = 
whole-organ MRI scoring), in which numerous features (cartilage 
signal and morphology, subchondral bone marrow abnormalities, 
meniscal and ligmament changes, etc.) are graded within the knee. 
The inter-observer agreement among two trained readers was high 
	JOUSBDMBTTDPSSFMBUJPODPFG¾DJFOU> 0.98 for cartilage abnormalities 
and > 0.80 for most features, except for bone attrition and synovitis) 
using a 1.5 T whole body magnet. Another compartment based 
scoring system, termed knee osteoarthritis scoring system (KOSS) 
has also been published, with intraobserver reproducibility of 
0.76 to 0.96 (ICC) and interobserver reproducibility (intraclass 
DPSSFMBUJPODPFG¾DJFOU
BNPOHTUUXPJOEFQFOEFOUPCTFSWFSTPG
to 0.91 16. Some limitations of these scoring systems have recently 
CFFO JEFOUJ¾FE 17 when applying the WORMS grading systems 
to knees of 336 subjects (3 readers) and comparing these with a 
Rasch measurement model. The authors commented that adding 
up individual scoring subscales, as recommended by WORMS, is 
problematic, and that several subscales (in particular those for 
cartilage signal and morphology, and for osteophytes) may need to 
be redeveloped. 
4BUJTGBDUPSZ TQFDJ¾DJUZ BOE TFOTJUJWJUZ GPS EFUFDUJOH DIPOESBM
lesions has been demonstrated in knee specimens and in vivo with 
BSUISPTDPQJD WFSJ¾DBUJPO 1-3,10-12,18. Bredella et al. 13 reported the 
TFOTJUJWJUZPGBOETQFDJ¾UZPGJOEFUFDUJOHDIPOESBMMFTJPOT
versus athroscopy, when axial and coronal images were combined, 
and values of 94%/99% when images in all three planes were 
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combined. In this study, accuracy was highest for severe cartilage 
lesions and lowest for minor lesions, particularly for signal intensity 
BMUFSBUJPOT6TJOHBQPSDJOFNPEFMPG BSUJ¾DJBM DBSUJMBHF MFTJPOT6 it 
was found the highest lesion detection rate with an intermediate-
weighted FSE sequence at 3.0 T (90% vs. 62% at 1.5T), whereas the 
lesion grade was most accurately evaluated with SPGR at 3.0T (83% 
versus 70% at 1.5 T). Receiver operator characteristics (ROC) analyses 
JO UIF TBNF NPEFM DPO¾SNFE JNQSPWFE EJBHOPTUJD QFSGPSNBODF
in detecting cartilage lesions at 3.0 T, if high resolution imaging 
QSPUPDPMT	TMJDFUIJDLOFTTNNBOEJOQMBOFSFTPMVUJPONN

were used 19. Quantitative measurements of cartilage lesion depth, 
diameter, area, and lesion volume have been validated in a porcine 
experimental model of OA 20. In human knee cartilage, the mean 
EJGGFSFODFCFUXFFONFBTVSFE BOE BDUVBM BSUJ¾DJBM DBSUJMBHFEFGFDU
diameters was reported to be < 0.1 mm, whereas the lesion depth 
was underestimated in MRI by > 0.4 mm 21. Graichen et al. 22 observed 
BOPWFSFTUJNBUJPOPGUIFUSVFTJ[FPGBSUJ¾DJBMDBSUJMBHFEFGFDUTJOUIF
human knee, which decreased from 42% in 3 mm defects to 4% in 
8 mm defects. Biswal et al. 14 retrospectively examined 43 patients 
aged 17 to 65 years) with an average observation period of 1.8 (range 
1 to 5) years. They reported that 147 cartilage lesions were prevalent 
at baseline, of which 12% were not detectable at follow up. Six % 
changed to a lower grade (excluding those that disappeared), 32% 
remained the same, and 50% progressed towards higher grades. 
84 new lesions occurred during the observation period. Grade 1A 
lesions observed at baseline (signal intensity alterations only) partly 
tended to progress towards morphological abnormality, whereas 
some of these lesions disappeared. 71% of the baseline lesions 
were seen in the medial and 29% in the lateral compartment of 
the femorotibial joint, and the incidence of new lesions was also 
higher medially (59%) than laterally (41%). Lesions in the central 
NFEJBM '5 DPNQBSUNFOUXFSF TJHOJ¾DBOUMZNPSF MJLFMZ UP QSPHSFTT
to higher grades than those in the anterior and posterior medial FT 
compartment . Subjects with meniscal tears and anterior cruciate 
ligament (ACL) repair tended to display a higher rate of progression 
than those without 14. In 86 healthy subjects without symptoms 
and radiographic OA, cartilage lesions were observed to progress 
more rapidly to higher grades in males than in females over a 2 year 
period 9. However, baseline cartilage defect scores were negatively 
associated with defect progression. The authors argued that some of 
cartilage lesions with highest defect scores may have regressed, but 
given the limited in-plane resolution of 0.3 mm x 0.8 mm in this study 
this observation may also be due to methodological limitations, with 
PWFSDMBTTJ¾DBUJPOPGMFTJPOTFWFSJUZJOTPNFCBTFMJOF.3*TDBOTUIBU
were not reproduced at follow-up. In a sibpair study of 115 subjects 
from 48 families followed over 2.4 years 23 it was reported that the 
adjusted heritability estimates for the progression of cartilage defects 
was 98% for the medial and 80% for the lateral FT compartment. In a 
sample of 117 subjects with symptomatic knee OA, those with higher 
UPUBMDBSUJMBHFEFGFDUTDPSFT	
BUCBTFMJOFXFSFBTTPDJBUFEXJUI
a 6.0 fold increase risk of joint replacement 4 years later compared 
XJUIUIPTFXJUIMPXFSDBSUJMBHFEFGFDUTDPSFT	

ad b): The MR sequences commonly used for evaluating cartilage 
repair are identical with those that have been used for evaluating 
cartilage lesions (T1-weighted SPGR or FLASH) with fat suppression 
1-5,5-9 or selective water excitation 10, or fat-suppressed T2- or 
IM- weighted fast spin echo sequences 4,6,11-14). The evaluation of 
the success of cartilage repair procedures 25-30 requires particular 
grading systems, one of which is MOCART 25,27,31,32. The validity 
and reliability of this system has been evaluated for the assessment 
of autologous chondrocyte transplantation (ACT) in the knee 25,
VTJOH  QFSUJOFOU WBSJBCMFT 5IFTF JODMVEFE ¾MMJOH PG UIF EFGFDU
integration of the border zone to the adjacent cartilage, intactness 
of the subchondral lamina, intactness of the subchondral bone, 
intensity of the signal intensities of the repair tissue compared to the 
adjacent native cartilage, and others. An almost perfect agreement 
( ICC >0.81) was found for 8 of the 9 variables. When comparing 
the MRI scores with clinical outcome (knee related quality of life) 2 
ZFBSTBGUFS"$5BTUBUJTUJDBMMZTJHOJ¾DBOUDPSSFMBUJPOXBT GPVOE GPS
²¾MMJOHPGUIFEFGFDU³²TUSVDUVSFPGUIFSFQBJSUJTTVF³²DIBOHFTJO
the subchondral bone,” and “signal intensities of the repair issue”. 
Studies using quantitative MRI to interrogate the composition of the 
cartilage matrix are of particular interest for the study of cartilage 
repair, as they have the potential to evaluate cartilage maturation and 
functional adaptation after surgery in vivo 33-37. The most promising 
techniques in this context include T2, T1Gd (= dGEMRIC index) and 
T1rho. Measurements of transverse relaxation times (T2) of articular 
cartilage provide a potential imaging biomarker of structural changes 
in the collagen matrix 38. Perturbation of the collagen architecture 
leads to increased T2-weighted signal intensity, whereas sites of 
decreased signal intensity can be observed adjacent to sites of focal 
cartilage injury 39. The majority of cartilage T2 mapping studies have 
used conventional multi-slice multi spin echo (MSME) sequences, 
typically with a minimum of 7 echoes. The in vivo precision errors 
of the technique have been reported recently 40. While increased 
cartilage T2 is associated with an increase in water content 41 and 
a decrease in collagen content 42 UIFEPNJOBOU GBDUPS JO¿VFODJOH
regional variation in T2 appears to be the anisotropic arrangement of 
the type II collagen matrix 43,44. A recent study has observed a strong 
JOWFSTF DPSSFMBUJPO PG ¾CFS BOJTPUSPQZ EFUFSNJOFE XJUI QPMBSJ[FE
light microscopy and the T2 of the cartilage 45. Whereas some 
studies have observed discrete differences of T2 between control 
and OA populations 46,47, others not 48,49. The low sensitivity of T2 to 
cartilage degeneration in clinical trials might be due to the fact that 
the disruption in collagen architectural structure and the increased 
hydration might lead to increases in T2, whereas the cleavage of 
collagen molecules and the resulting increased water interaction 
sites might lead to decreases in T2, with the effects compensating 
each other. However, the sensitivity of T2 to collagen architecture 
has been successfully applied to study maturational changes in the 
collagen matrix of osteochondral plugs from juvenile animals 50,51
and age-related changes in mature cartilage 52-54.
dGEMRIC relies on preferential distribution of the MRI contrast agent 
GdDTPA2- (Magnevist) into cartilage with low glycosaminoglycan 
content 55,56. 3D applications of dGEMRIC that provide greater 
coverage and faster imaging times are currently undergoing 
validation 57,58. When applying dGEMRIC to th evaluation of cartilage 
repair, however, it must be taken into account that in contrast to 
studies in normal (and potentially degenerative) cartilage, post-
contrast imaging (approximately 90 mins after intravenous injection 
of Gd-DTPA) does not correlate with glycosaminoglycan content, 
but the difference between pre- and post-contrast imaging does 
59. Therefore, pre- and post-contrast imaging may be necessary for 
successful evaluation of reparative cartilage after ACI using dGEMRIC 
59.
The combination of T2 mapping and dGEMRIC provides the unique 
opportunity to evaluate biomechanical properties of cartilage tissue 
in vivo 60, which may be of particular help in postoperatively evaluating 
the success of cartilage repair 32,61-63. Longer heterogeneous 
T2 values were observed in repair tissue following autologous 
chondrocyte implantation (ACI) 64, whereas the dGEMRIC scores in 
the repair tissue were similar to those observed in normal cartilage, 
suggesting replenishment of proteoglycan 10 to 15 months after ACI 
64. Following arthroscopic osteochondral autograft transplantation 
(OAT), the normal decrease in cartilage T2 with respect to depth from 
the articular surface was predictive of hyaline cartilage histology, 
XIJMF IFUFSPHFOFPVT 5 WBMVFT XFSF JOEJDBUJWF PG ¾CSPDBSUJMBHF
repair tissue 65.
T1rho is another emerging technique for evaluating proteoglycans 
66, but has also been shown to be sensitive to collagen 42. Rapid 3D 
T1rho techniques have recently been developed 67,68. Although 
less widely available than T2 mapping studies, initial evaluation in 
a small number of subjects suggest it may be more responsive to 
cartilage damage associated with OA 47,69.
ad c): Methods for quantitative evaluation of articular cartilage 
morphology (e.g. volume and thickness), mainly in the context of 
monitoring progression of osteoarthritis (OA) have been widely 
applied and published over recent years 33,70,70,71. A nomenclature for 
MRI-based measurements of cartilage morphology and composition 
has recently been presented 72. These techniques have been mainly 
applied in the context of functional adaptation of articular tissues 
to mechanical loading 70,73-77 and in monitoring osteoarthritic 
(degenerative) changes 33,71,78-80. A recent study 81 has evaluated the 
feasibility of quantitative MRI analysis of cartilage morphology in 21 
patients after autologous chondrocyte implantation (ACI). Sagittal 
fat-suppressed 3D FLASH sequences were obtained pre and 1-year 
post-ACI surgery in the femoral condyles. The cartilage volume, 
mean cartilage thickness and size of the cartilage-bone interface 
were determined. Susceptibility artifacts were a problem in 3 of the 
QBUJFOUT UIFSFQSPEVDJCJMJUZFSSPS 	DPFG¾DJFOUPGWBSJBUJPO
PG
cartilage volume measurement was 3.9%/4.4% for the medial and 
lateral tibia, respectively, and 5.1% for the femur. A 6% increase of 
cartilage volume and thickness was observed in the treated femora 
(P<8JMDPYPO
 SFMBUJWF UP UIFQSF01EBUB CVU OP TJHOJ¾DBOU
change in the (non-operated) tibiae. Sensitivity to change for femoral 
cartilge was improved when evaluating only the treated portion of 
the femur in contrast to the total femur. Morphological cartilage 
analysis following cartilage repair procedures may help to determine 
the effectiveness in these procedures to stop degenerative disease 
progression. 
Recently, the Osteoarthritis Initiative (OAI) has been started. This 
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is a multi-center prospective cohort study in approximately 5000 
participants, which is supported by a private public partnership 
between the NIH, NIAMS and the pharmaceutical industry (http://
www.niams.nih.gov/ne/oi/) 71,82-86. This study provides a large 
public data base of MR images and other clinical, radiological and 
serum biomarker data, targeted at identifying the most reliable 
and sensitive biomarkers for evaluating the development and 
progression of symptomatic knee OA. This study may also provide a 
potential source for studying cartilage repair. 
In summary, exciting technologies have been developed for 
evaluating cartilage in vivo. The major challenge is the clinical 
validation of imaging outcomes (correlation with how a patient 
feels and functions) 25,79,84,87-89. Additional studies will be needed to 
determine whether MRI is prognostic of clinical outcome, and could 
replace arthroscopic biopsy for monitoring repair tissue histology. 
The major challenge lays not so much in the continued improvement 
of these tools, but in validating their correlation with clinical 
outcomes. 
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24.2
Multidetector CT arthrography: back to the future
C. Winalski, United States of America 
Multidetector computed tomographic arthrography (MDCT-A) is an 
emerging technology for the assessment of articular disorders. A 
number of recent reports using this method have shown excellent 
results for the evaluation of intraarticular structures rivaling or 
exceeding the expectations of MR. In our early experience, we 
have found MDCT-A and magnetic resonance (MR) imaging to 
be complimentary examinations, each with its strengths and 
weaknesses. 
$5BSUISPHSBQIZJTOPUBOFXQSPDFEVSF*UXBT¾STUJOUSPEVDFEJOUIF
1980’s for the evaluation of knee menisci and the glenoid labrum. 
However, the CT technology at that time was limited to sequential, 
relatively thick slices of 1-2 mm that did not produce adequate 
multiplanar reformatted images for the evaluation of small structures 
in the sagittal and coronal plane. Since the examinations were limited 
to the axial plane, the technique was limited to those structures 
that could be visualized through proper positioning of the patient, 
and it was not widely adopted. The technological advancements of 
helical scanning and multidetector data acquisition provide images 
with near isotropic voxel dimensions that may be reformatted in any 
plane with nearly equal resolution to the plane of acquisition. Thus, 
coronal, sagittal and oblique images may be created from a single 
axial acquisition. Image resolution can be greater than that typically 
obtained by MR. Additionally, image acquisition times for joint 
imaging are one to two minutes for an entire exam rather than the 20 
to 45 minutes usually needed to acquire all of the image acquisitions 
for MR. However, MDCT-A exposed the patient to ionizing radiation 
while MR does not. 
CT without arthrography has limited image contrast between soft 
tissues when compared to MR, and intraarticular structures cannot 
be adequately evaluated. However, following intraarticular injection 
of iodinated radiographic contrast, the surfaces of the articular 
cartilage, menisci, labra and ligaments are outlined, and defects and 
UFBSTNBZCF¾MMFECZDPOUSBTUBHFOUSFTVMUJOHJOWBTUJNQSPWFNFOUT
in the visualization of these structures. 
Our protocol for a typical MDCT-A examination calls for the intra-
articular injection of iodinated contrast diluted to 150 mgI/ml to 
make the injectate near iso-osmolar. Depending on the particular 
contrast agent, full strength (300 mgI/ml or greater) may be double 
the osmolarity of serum and, following intraarticular injection, 
NBZ SFTVMU JOQPTUQSPDFEVSFQBJODBVTFECZBO JO¿VYPG¿VJEBOE
overdistention of the joint. Full strength contrast may be used in 
the knee if the injected volume is limited to 20cc and the patient 
is warned that their knee will continue to swell for several hours. 
8F QFSGPSN UIF JOKFDUJPOT VOEFS ¿VPSPTDPQJD HVJEBODF XJUI B
large enough volume to distend the joint (approximately 20cc for 
the knee, 14cc for the shoulder, 10cc for the hip). Imaging is then 
performed as quickly as possible following injections, ideally within 
15 minutes and no more than 30 minutes. If a gadolinium chelate MR 
contrast agent is added to the injectate, both an MDCT-A and an MR 
arthrogram can be performed following a single injection.1 If this is 
EPOFUIF.%$5"TIPVMECFBDRVJSFE¾STUTJODFUIFUJNJOHPGUIF.3
following injection appears to be less crucial. 
As with MR imaging, the details of the acquisition and reconstruction 
parameters for MDCT-A are critical for success. The slice thickness 
(< 1mm) and pitch (< 0.8) should be minimized, and the slice overlap 
NBYJNJ[FE 	
 $BSF TIPVME CF UBLFO UIBU UIF NVMUJQMBOBS
reconstructions have an adequate signal to noise ratio (SNR). Our 
protocol uses direct axial images reconstructed at 0.6 mm with 
40% overlap. Reformatted images in 3 anatomic planes (true axial, 
coronal and sagittal) that are 2mm thick are then created every 1mm. 
By optimizing the scan parameters, excellent results can be obtained 
even from dual row multidetector equipment.2
In 2000, some of the initial work on MDCT-A was reported for 
studies of the knee and shoulder.3, 4 Vande Berg et al. showed 
FYDFMMFOU TFOTJUJWJUZ BOE TQFDJ¾DJUZ GPS UIF EFUFDUJPO PG NFOJTDBM
tears4 and anterior cruciate ligament tears,5 and that MDCT-A 
is able to demonstrate articular cartilage defects.6 In an in vitro 
cadaveric analysis of the ankle, El-Khoury et al. showed MDCT-A was 
more accurate than MR in the determination of articular cartilage 
thickness.7 In clinical study of the wrist, MDCT-A proved more 
accurate than either MR or MR-arthrography for the diagnosis of 
ligament tears and cartilage lesions.1
In our clinical practice, we have begun exploring the use of MDCT-
